305 related articles for article (PubMed ID: 30631322)
1.
Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
Front Immunol; 2018; 9():2920. PubMed ID: 30631322
[TBL] [Abstract][Full Text] [Related]
2. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR
Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.
Hungria EM; Freitas AA; Pontes MA; Gonçalves HS; Sousa AL; Costa MB; Castilho ML; Duthie MS; Stefani MM
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):328-334. PubMed ID: 28126361
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
[TBL] [Abstract][Full Text] [Related]
5. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
Assis BPN; Chaves AT; Lage DP; Cardoso MM; Freitas CS; Pereira IAG; Câmara RSB; Martins VT; de Oliveira ALG; Machado-de-Ávila RA; Galdino AS; Chávez-Fumagalli MA; Christodoulides M; Gonçalves DU; Bueno LL; Fujiwara RT; Coelho EAF; da Costa Rocha MO
Tuberculosis (Edinb); 2024 Jul; 147():102505. PubMed ID: 38583359
[TBL] [Abstract][Full Text] [Related]
7. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
Chen X; You YG; Yuan YH; Yuan LC; Wen Y
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
10. Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.
Duthie MS; Sampaio LH; Oliveira RM; Raman VS; O'Donnell J; Bailor HR; Ireton GC; Sousa AL; Stefani MM; Reed SG
Vaccine; 2013 Jan; 31(5):813-9. PubMed ID: 23228811
[TBL] [Abstract][Full Text] [Related]
11. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
[TBL] [Abstract][Full Text] [Related]
12. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
[TBL] [Abstract][Full Text] [Related]
15. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific T-cell responses of leprosy patients.
Duthie MS; Goto W; Ireton GC; Reece ST; Sampaio LH; Grassi AB; Sousa AL; Martelli CM; Stefani MM; Reed SG
Clin Vaccine Immunol; 2008 Nov; 15(11):1659-65. PubMed ID: 18784342
[TBL] [Abstract][Full Text] [Related]
17. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
[TBL] [Abstract][Full Text] [Related]
18. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
[TBL] [Abstract][Full Text] [Related]
19. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
20. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
